Markets:

Overview

News

Currencies

International

Treasuries

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

13.04 -0.41 (-3.05%)

Official Closing Price Updated: 8:00 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

In today's session, these stocks are experiencing unusual volume. ↗

August 20, 2025

On Wednesday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

Nasdaq Down 1%; Lowe's Posts Upbeat Earnings ↗

August 20, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

August 20, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

August 20, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

Dow Surges 100 Points; Target Shares Fall After Q2 Results ↗

August 20, 2025

Via Benzinga

Topics Stocks

Wednesday's pre-market session: top gainers and losers ↗

August 20, 2025

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 20, 2025

Via Benzinga

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

August 20, 2025

Via Benzinga

NovaBay Pharmaceuticals Soars 66% In Pre-Market On $6 Million Investment Deal, CEO Appointment ↗

August 20, 2025

NovaBay Pharmaceuticals Inc. jumps 66.57% to $1 in pre-market trading after major investment and leadership changes prevent liquidation.

Via Benzinga

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

March 07, 2025

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Get insights into the top gainers and losers of Friday's pre-market session. ↗

February 28, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 05, 2025

Via Benzinga

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

January 23, 2025

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 13, 2025

Via Benzinga

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

December 19, 2024

From NovaBay Pharmaceuticals

Via Business Wire

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

December 09, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

November 22, 2024

From NovaBay Pharmaceuticals

Via Business Wire

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

November 07, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

November 06, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand

November 15, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 29, 2024

Via Benzinga

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

October 29, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

What's Going On With NovaBay Pharmaceuticals Shares Friday? ↗

September 20, 2024

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals.

Via Benzinga

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders

September 20, 2024

From Halper Sadeh LLC

Via Business Wire

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

September 20, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗

August 13, 2024

NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

August 13, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

August 01, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

July 30, 2024

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

What's Going On With NovaBay Pharmaceuticals (NBY) Stock? ↗

July 29, 2024

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.